Fri, August 4, 2023

Joseph Stringer Reiterated (VIR) at Strong Buy and Held Target at $22 on, Aug 4th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-22-on-aug-4th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Stringer of Needham, Reiterated "Vir Biotechnology, Inc." (VIR) at Strong Buy and Held Target at $22 on, Aug 4th, 2023.

Joseph has made no other calls on VIR in the last 4 months.



There are 4 other peers that have a rating on VIR. Out of the 4 peers that are also analyzing VIR, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michelle Gilson of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, July 21st, 2023


These are the ratings of the 3 analyists that currently disagree with Joseph


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $41 on, Friday, July 21st, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $28 on, Friday, July 21st, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $100 on, Thursday, July 20th, 2023

Publication Contributing Sources